NASDAQ:ESPR   Esperion Therapeutics, Inc.
ESPR is oversold according To RSi. Looks like it has gapped down to a support area. Billion Dollar company- dont think it will be going broke anytime soon. More than likely they have other products going on. And supposedly the news isnt as bad as it seems. there is a law suit pending which could drive the stock down more. So keep on your watch list.
Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.